Meds and you

27 September 2013

Fluocinolone

Fluocinolone is a topical corticosteroid. Topical corticosteroids are steroid medicines that are formulated for use on the skin.

0

Fluocinolone is the active ingredient of Cortoderm cream (Nappi code: 716278-006), Cortoderm cream (Nappi code: 716278-014), Cortoderm ointment (Nappi code: 716286-009), Cortoderm ointment (Nappi code: 716286-017), Synalar cream (Nappi code: 768278-007), Synalar ointment (Nappi code: 768286-018) and Synalar gel (Nappi code: 768294-002).

General information

Fluocinolone is a topical corticosteroid. Topical corticosteroids are steroid medicines that are formulated for use on the skin. They reduce inflammation and are effective for treating inflammatory skin conditions.

In South Africa fluocinolone is registered for the treatment of non-infected steroid responsive diseases and disorders affecting the skin.

This medication should be applied sparingly and as a thin, even layer to the affected area of the skin. Do not apply to broken skin, or apply more than directed.

Prolonged use on large surface areas, application of large amounts, or covering the application site with dressings may increase systemic absorption, resulting in a decrease in the production of natural hormones by the adrenal glands. Prolonged or excessive use of this medicine may lead to thinning of the skin.

Avoid contact with the eyes and do not apply to skin crease or ano-genital areas and nappy areas of infants. If applied to the face, use for short periods only.

Speak to your doctor before applying this medicine to infected skin.

How does fluocinolone work?

When applied to the skin, fluocinolone reduces the release of inflammatory chemicals. This reduces inflammation and its associated symptoms.

Fast facts

Drug schedule: schedule 4

Available as: fluocinolone is available as cream, ointment and gel.

What does it do? Fluocinolone relieves inflammation of the skin.

Overdose risk: low

Dependence risk: low

Is fluocinolone available as a generic? yes

Is fluocinolone available on prescription only? yes

User information

Stopping this medicine: do not stop using this medication abruptly as it may cause a recurrence of the original symptoms being treated. Consult with your doctor prior to discontinuing treatment.

Prolonged use: this medicine is not intended for long-term use as this may lead to permanent skin changes. Safety of use for more than 5 days has not been established.

Special precautions

Consult your doctor before using this drug if:

  • you have a bacterial, fungal or viral skin infection
  • you have porphyria
  • you have skin ulcers/broken skin
  • you have acne or rosacea

Pregnancy: avoid. It is unknown how this medication may affect your baby. Consult your doctor before using this drug, or if you are planning to fall pregnant.

Breastfeeding: avoid. It is unknown how this medication may affect your baby. Consult your doctor before use.

Porphyria: avoid. This medication may cause serious adverse effects. Consult your doctor before use.

Infants and children: this medication is not intended for use in children under the age of 1 year.

The elderly: no special precautions need to be taken.

Driving and hazardous work: no special precautions need to be taken.

Alcohol: no special precautions need to be taken.

Possible side effects

Side effects Frequency
Consult your doctor

Common Rare Only if severe In all cases
burning x
x
itching x
x
skin irritation
x
x
skin infections
x
x
systemic effects
x
x

Interactions

Drug interactions

Interactions are uncommon when this medication is used as directed.

Overdose action

A small overdose is no cause for concern. In case of intentional large overdose, seek emergency medical attention.

Recommended dosage

Apply sparingly to the affected area 2 - 3 times daily.

______________________________________________________________________________

This material is not intended to substitute medical advice, but is for informational purposes only.

Please consult a physician for specific treatment and recommendations.

 
 

Read Health24’s Comments Policy

Comment on this story
0 comments
Comments have been closed for this article.